Skip to content
healthcare.dev

TYRUKO

NDC 61314-543, natalizumab-sztn, injection, from Sandoz Inc.

Product NDC
61314-543
Status
Listed
Labeler
Sandoz Inc
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761322
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/61314-543 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NATALIZUMAB300 mg/15mL

Pharmacologic classes

Integrin Receptor Antagonist [EPC]; Integrin Receptor Antagonists [MoA]

Package NDCNDC-11Package
61314-543-94613140543941 VIAL, SINGLE-DOSE in 1 CARTON (61314-543-94) / 15 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ef653c36-dd4b-4e71-9d2d-40b8fea24b67
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=61314-543

Use it

Look up 61314-543 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/61314-543 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 61314-543. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.